IVSX Fees and Costs — Applied Finance IVS International SMID ETF
Data updated: 2026-08-26
The net expense ratio is 75.00%. There are no sales loads or redemption fees.
IVSX Fees and Expenses
Annual operating expenses and sales charges of IVSX. Prospectus, as of April 30, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 75.00% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 75.00% |
| Fee waiver | — |
| Net expense ratio | 75.00% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
IVSX Costs Over Time
On $10,000 invested in IVSX, assuming 5% a year before costs, total costs come to $12,750 over 5 years, cutting the return by 78.75% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 75.00%) | $7,875 | $10,485 | $10,665 |
| Lost growth on money paid in costs | $0 | $911 | $2,086 |
| Total costs | $7,875 | $11,395 | $12,750 |
| Value after costs | $2,625 | $181 | $12 |
| Impact on return, per year | 78.75% | 78.75% | 78.75% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.